Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Effects on Cerebral Autoregulation in SAH
NCT01664520Phase 2Completed
- Sponsor
- Turku University Hospital
- Start
- Jun 2013
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in subarachnoid hemorrhage (SAH), sponsored by Turku University Hospital. Started Jun 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT01664520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01664520.